---
layout: paper
title: "Dynamics of neutralizing antibody titers in the months after severe acute respiratory syndrome coronavirus 2 infection"
date: "2021-01-15"
authors: 
    - "Katharine HD Crawford"
    - "Adam S Dingens"
    - "Rachel Eguia"
    - "Caitlin R Wolf"
    - "Naomi Wilcox"
    - "Jennifer K Logue"
    - "Kiel Shuey"
    - "Amanda M Casto"
    - "Brooke Fiala"
    - "Samuel Wrenn"
    - "Deleah Pettie"
    - "Neil P King"
    - "Alexander L Greninger"
    - "Helen Y Chu"
    - "Jesse D Bloom"
journal: "The Journal of infectious diseases"
doi: "10.1093/infdis/jiaa618"
link: "https://academic.oup.com/jid/article/223/2/197/5916372"
image: "/assets/papers/starr_greany_2020.png"
---

## Abstract

Most individuals infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) develop neutralizing antibodies that target the viral spike protein. In this study, we quantified how levels of these antibodies change in the months after SARS-CoV-2 infection by examining longitudinal samples collected approximately 30â€“152 days after symptom onset from a prospective cohort of 32 recovered individuals with asymptomatic, mild, or moderate-severe disease. Neutralizing antibody titers declined an average of about 4-fold from 1 to 4 months after symptom onset. This decline in neutralizing antibody titers was accompanied by a decline in total antibodies capable of binding the viral spike protein or its receptor-binding domain. Importantly, our data are consistent with the expected early immune response to viral infection, where an initial peak in antibody levels is followed by a decline to a lower plateau. Additional studies of long-lived B cells and antibody titers over longer time frames are necessary to determine the durability of immunity to SARS-CoV-2.
